Medline (MDLN) Other Non-Current Assets (2024 - 2026)

Medline (MDLN) has 3 years of Other Non-Current Assets data on file, last reported at $446.0 million in Q1 2026.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $446.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $446.0 million (changed N/A YoY) and the FY2025 annual result came in at $472.0 million, down 3.08% from the prior year.
• Other Non-Current Assets eased to $446.0 million in Q1 2026 per MDLN's latest filing, from $472.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $487.0 million in Q4 2024 and bottomed at $446.0 million in Q1 2026.
• The 3-year median for Other Non-Current Assets is $472.0 million (2025), against an average of $468.3 million.
• Peak annual rise in Other Non-Current Assets reached 3.08% in 2025, while the deepest fall reached 3.08% in 2025.
• Tracing MDLN's Other Non-Current Assets over 3 years: stood at $487.0 million in 2024, then slipped by 3.08% to $472.0 million in 2025, then retreated by 5.51% to $446.0 million in 2026.
• Per Business Quant, the three latest MDLN Other Non-Current Assets figures stand at $446.0 million (Q1 2026), $472.0 million (Q4 2025), and $487.0 million (Q4 2024).

Peer Comparison